Clinical Trial Update: Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer [NA]

View source ↗

Summary

Completed clinical trial comparing Blue Citrus to placebo in postmenopausal women with estrogen receptor-positive breast cancer receiving aromatase inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Blue Citrus

Snippet

Sponsor: Legacy Health System | Conditions: Breast Cancer, Joint Pain | NA | Status: COMPLETED